scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1007459824 |
P356 | DOI | 10.1186/BCR2105 |
P932 | PMC publication ID | 2481501 |
P698 | PubMed publication ID | 18534028 |
P5875 | ResearchGate publication ID | 5323632 |
P2093 | author name string | Peter H Watson | |
Nathan R West | |||
Jiaxu Wang | |||
Jenny E Chu | |||
Melanie Olson | |||
Rebecca O Barnes | |||
P2860 | cites work | S100A7 and the progression of breast cancer | Q22000741 |
Psoriasin (S100A7) expression and invasive breast cancer | Q22010926 | ||
Psoriasin expression in mammary epithelial cells in vitro and in vivo | Q24292122 | ||
A putative role for psoriasin in breast tumor progression | Q24298889 | ||
A new group of conserved coactivators that increase the specificity of AP-1 transcription factors | Q24310680 | ||
Jab1 antagonizes TGF-beta signaling by inducing Smad4 degradation | Q24522552 | ||
COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system | Q24545648 | ||
Gene expression signature of estrogen receptor alpha status in breast cancer | Q24805289 | ||
S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast | Q24805971 | ||
Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1 | Q28138425 | ||
JAB1 interacts with both the progesterone receptor and SRC-1 | Q28139007 | ||
Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1 | Q28139243 | ||
COP9 signalosome-directed c-Jun activation/stabilization is independent of JNK | Q28139466 | ||
Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity | Q28141877 | ||
Psoriasin interacts with Jab1 and influences breast cancer progression | Q28191754 | ||
The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex | Q28204773 | ||
Jab1 interacts directly with HIF-1alpha and regulates its stability | Q28205085 | ||
Clustered organization of S100 genes in human and mouse | Q28295343 | ||
HER2-targeting antibodies modulate the cyclin-dependent kinase inhibitor p27Kip1 via multiple signaling pathways | Q28299421 | ||
Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells | Q30438933 | ||
JAB1/CSN5 interacts with the GAL4 DNA binding domain: a note of caution about two-hybrid interactions | Q30772126 | ||
A SAGE (serial analysis of gene expression) view of breast tumor progression. | Q30998378 | ||
The Clinical Significance of Epidermal Growth Factor Receptor (EGF-R) in Human Breast Cancer: A Review on 5232 Patients* | Q33188817 | ||
S100A7-downregulation inhibits epidermal growth factor-induced signaling in breast cancer cells and blocks osteoclast formation | Q33322536 | ||
The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers | Q33943227 | ||
Studies of epidermal growth factor receptor inhibition in breast cancer | Q34376342 | ||
Genetic regulators of large-scale transcriptional signatures in cancer | Q34537800 | ||
Predicting a local recurrence after breast-conserving therapy by gene expression profiling | Q35605850 | ||
NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis | Q35971557 | ||
Clinical value of epidermal growth factor receptor expression in primary breast cancer | Q36279731 | ||
Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer | Q36604000 | ||
C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance | Q36621638 | ||
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer | Q36678853 | ||
Inductive mechanisms limiting response to anti-epidermal growth factor receptor therapy. | Q36720713 | ||
CSN5 isopeptidase activity links COP9 signalosome activation to breast cancer progression | Q37106255 | ||
Jab1 is overexpressed in human breast cancer and is a downstream target for HER-2/neu. | Q40017171 | ||
The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer | Q40402282 | ||
Akt-dependent T198 phosphorylation of cyclin-dependent kinase inhibitor p27kip1 in breast cancer. | Q40530643 | ||
Predicting continuous values of prognostic markers in breast cancer from microarray gene expression profiles. | Q40585484 | ||
Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells. | Q40628338 | ||
The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients | Q40665439 | ||
PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest | Q40702262 | ||
c-myc oncogene expression in estrogen-dependent and -independent breast cancer | Q40875264 | ||
Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer | Q41090487 | ||
The constitutive photomorphogenesis 9 signalosome directs vascular endothelial growth factor production in tumor cells. | Q42513620 | ||
Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer | Q44509716 | ||
Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer. | Q47343720 | ||
EGF-R and steroid receptors in breast cancer: a comparison with tumor grading, tumor size, lymph node involvement, and age. | Q47392457 | ||
HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer | Q61853774 | ||
Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1) | Q64377657 | ||
Epidermal growth factor receptor and other oncogenes as prognostic markers | Q68201105 | ||
Refined mapping of the psoriasin gene S100A7 to chromosome 1cen-q21 | Q70807777 | ||
Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma | Q71614084 | ||
Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer | Q77673978 | ||
P433 | issue | 3 | |
P304 | page(s) | R51 | |
P577 | publication date | 2008-06-06 | |
P1433 | published in | Breast Cancer Research | Q2208481 |
P1476 | title | Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer | |
P478 | volume | 10 |
Q39555290 | Bezielle (BZL101)-induced oxidative stress damage followed by redistribution of metabolic fluxes in breast cancer cells: a combined proteomic and metabolomic study |
Q24315611 | COP9-associated CSN5 regulates exosomal protein deubiquitination and sorting |
Q37063329 | COPS5 amplification and overexpression confers tamoxifen-resistance in ERα-positive breast cancer by degradation of NCoR. |
Q90330859 | CSN5 controls the growth of osteosarcoma via modulating the EGFR/PI3K/Akt axis |
Q24319983 | Dynamic regulation of the COP9 signalosome in response to DNA damage |
Q39766695 | High-throughput profiling of tissue and tissue model microarrays: Combined transmitted light and 3-color fluorescence digital pathology. |
Q47153479 | Increased Jab1/COPS5 is associated with therapeutic response and adverse outcome in lung cancer and breast cancer patients |
Q38708092 | Inhibiting epidermal growth factor receptor signalling potentiates mesenchymal-epithelial transition of breast cancer stem cells and their responsiveness to anticancer drugs |
Q34292695 | JAB1/CSN5: a new player in cell cycle control and cancer |
Q52657204 | Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer. |
Q39623720 | Psoriasin (S100A7) associates with integrin β6 subunit and is required for αvβ6-dependent carcinoma cell invasion. |
Q34180715 | Regulation of the human catalytic subunit of telomerase (hTERT). |
Q39747948 | S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer. |
Q36327912 | Targeting Jab1/CSN5 in nasopharyngeal carcinoma |
Q26782011 | The Role of the COP9 Signalosome and Neddylation in DNA Damage Signaling and Repair |
Search more.